Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Regulatory News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cancellation - Redx Pharma Plc

1 May 2024 07:00

RNS Number : 6373M
AIM
01 May 2024
 

NOTICE

 

01/05/2024 - 07:00

 

NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM

 

At the request of the company the following securities have been cancelled from trading on AIM with effect from the time and date of this notice.

 

REDX PHARMA PLC

213800HMS4EBXO589Y37

ORDINARY SHARES OF 1P EACH FULLY PAID

(BSNB6S5)(GB00BSNB6S51)

REDX PHAR/PAR VTG FPD 0.01

 

If you have any queries or require further information, please contact the company's nominated adviser.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AMOSDFFFSELSEEL
Date   Source Headline
13th Apr 201612:06 pmRNSResult of General Meeting and Issue of Equity
4th Apr 20162:58 pmRNSGrant of Options
4th Apr 201612:59 pmRNSResult of General Meeting
4th Apr 20167:00 amRNSIssue of Equity
29th Mar 20167:00 amRNSDirector/PDMR Shareholding
24th Mar 20161:55 pmRNSPlacing to Raise £10 Million
8th Mar 20167:00 amRNSChange of Adviser
24th Feb 201612:39 pmRNSResult of AGM
24th Feb 20167:00 amRNSAGM Statement
22nd Jan 20169:09 amRNSHardman & Co Research Report: Pipeline progress
22nd Jan 20167:30 amRNSHardman & Co Research Report: Pipeline progress
20th Jan 20167:00 amRNSFinal Results
6th Jan 20167:00 amRNSNotice of Results
4th Jan 20167:00 amRNSAppointment of Non-Executive Director
3rd Dec 20157:00 amRNSFourth drug development candidate
10th Nov 20157:00 amRNSRe BioInfect Conference 2015
5th Nov 20157:00 amRNSSenior management appointments
23rd Oct 20152:57 pmRNSRe Review on Antimicrobial Resistance
1st Oct 20157:00 amRNSTrading Update
3rd Sep 20157:00 amRNSCancer Research Collaboration with Redx Pharma
3rd Sep 20157:00 amRNSCancer Research Collaboration
22nd Jun 20157:00 amRNSHalf Yearly Report
19th Jun 20155:14 pmRNSHolding(s) in Company
4th Jun 20159:45 amRNSHolding(s) in Company
2nd Jun 20157:00 amRNSDiscovery of breakthrough MRSA compound
26th May 20157:01 amRNSSecond drug development candidate identified
14th May 20157:00 amRNSRe Review on Antimicrobial Resistance
14th May 20157:00 amRNSLaunch of third subsidiary, Redx Immunology
11th May 20157:00 amRNSPre-Clinical Proof of Concept with Oncology Lead
31st Mar 20155:13 pmRNSHolding(s) in Company
31st Mar 20151:35 pmRNSHolding(s) in Company
31st Mar 20151:33 pmRNSHolding(s) in Company
31st Mar 20159:37 amRNSHolding(s) in Company
27th Mar 20157:00 amRNSAdmission to AIM and First Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.